HIKAL
HIKAL LIMITEDHealthcare
LTP
227.14
CHG · %
+5.71 (+2.58%)
VOL · TODAY
8.12L
PREV CLOSE
221.43
Today's range216.02 · 230
227.14
52-week range146.25 · 319
227.14
Loading candles…
Hikal Ltd. operates in the pharmaceuticals, crop protection, specialty chemicals, and life sciences industries, providing active pharmaceutical ingredients (APIs), intermediates, contract development and manufacturing organization (CDMO) services, and research services. The company serves innovator and generic companies globally with integrated research and manufacturing capabilities. Its manufacturing facilities for crop protection products are located in Taloja and Mahad in Maharashtra, while pharmaceutical manufacturing occurs in Jigani (Bengaluru) and Panoli (Gujarat). Hikal's research and development center is based in Pune. These manufacturing facilities have undergone inspection and received approval from leading multinational companies in the crop protection and pharmaceutical sectors. The company has presence in North America, Europe, Japan, and India. No information on founders, key management, subsidiaries, or listings is provided.
HIKAL is not part of any active scan today.
This page is a live market overview for HIKAL LIMITED (HIKAL) on the NSE. As a listed security, HIKAL LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for HIKAL before placing trades on tick2trade.
As of the latest feed, HIKAL last traded at ₹227.14 on NSE, up ₹5.71 (2.58%) from the previous close of ₹221.43. Today's session range is ₹216.02 – ₹230, against a 52-week band of ₹146.25 – ₹319. Traded volume today stands at 8.12L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for HIKAL in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether HIKAL is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for HIKAL LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in HIKAL. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated HIKAL option chain page linked from this overview.
// similar in healthcare314 total